Annual Report 2014 Zinzino AB (publ)

Zinzino (publ) announces that the Annual Report in English for 2014 is now published on the company’s website, www.zinzino.com.

In the Annual Report, information is communicated that has not previously been communicated to the market. The company clarifies this by the following message:

-Zinzino showed strong growth in the first quarter of 2015. Total income amounted to SEK 106.2m (75.5) representing a growth of 41%.

- The acquisition of Faun Pharma AS has brought greater Goodwill than was communicated in Zinzino’s Year-end Report for 2014. Goodwill related to the acquisition of Faun Pharma AS amounts to SEK 12m in the Annual Report, which is SEK 2m higher than previously announced.

For more information, please contact:
Dag Bergheim Pettersen, CEO, Zinzino, Tel. +47 (0) 93 22 57 00
Fredrik Nielsen, CFO, Zinzino, Tel. +46 (0) 707 900 174
Photos for publication free of charge, please contact: Anders Ekhammar, Tel. +46 (0) 707 462 579,
www.zinzino.com

Zinzino AB (publ.) is a leading direct sales company with a presence in Sweden, Norway, Denmark, Finland, Estonia, Latvia, Lithuania, Iceland, the Faroe Islands, Poland, the Netherlands and the USA. Zinzino markets and sells functional food and coffee. The functional food product line comprises the Balance products oils, shakes, tests and capsules. The coffee product line comprises espresso machines, coffee, tea and accessories. Activities are characterised by high quality, proximity to customers and focus on active product development. The products are marketed via direct sales. Zinzino is a public limited company whose shares are listed on Nasdaq First North. The company has some 60 employees, and as well as the head office in Gothenburg the company has an office in Florida in the USA. The company also owns a production company, Faun Pharma AS, which employs 30 staff and is located in Vestby, outside Oslo in Norway.

Tags:

About Us

Zinzino AB (publ.) is a direct sales company which operates through the EU, Norway, Iceland and in North America. Zinzino markets and sells products in two product lines: Zinzino Health, with a focus on long-term health, and Zinzino Coffee, consisting of espresso machines, coffee and tea. Zinzino owns Norwegian BioActive Foods AS and the research and production unit Faun Pharma AS. Zinzino has over 120 employees. The company has its registered office in Gothenburg, and offices in Helsinki, Riga, Oslo and in Florida, United States. Zinzino is a public limited company and its shares are listed on Nasdaq First North.